An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease

Clinical trial NCT02293915 · COMPLETED

Trial details

NCT number: NCT02293915
Sponsor: Shanghai Greenvalley Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mild to Moderate Alzheimer Disease Cognitive Impairment

Start date: 2014-04-01
Primary completion: 2018-06-29
Enrollment: 818

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.